Koers Takeda Pharmaceutical Company Limited OTC Markets
Aandelen
TKPHF
JP3463000004
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
26,86 USD | +3,47% | +3,47% | -6,49% |
Omzet 2024 | 4.264 mld. 27,42 mld. 25,17 mld. | Omzet 2025 * | 4.252 mld. 27,34 mld. 25,1 mld. | Marktkapitalisatie | 6.613 mld. 42,52 mld. 39,04 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | 144 mld. 926 mln. 851 mln. | Nettowinst (verlies) 2025 * | 116 mld. 749 mln. 687 mln. | EV/omzet 2024 | 1,54 x |
Nettoschuld 2024 * | 3.771 mld. 24,25 mld. 22,26 mld. | Nettoschuld 2025 * | 4.224 mld. 27,16 mld. 24,94 mld. | EV/omzet 2025 * | 2,55 x |
K/w-verhouding 2024 |
45,4
x | K/w-verhouding 2025 * |
59,8
x | Werknemers | 49.095 |
Dividendrendement 2024 |
4,49% | Dividendrendement 2025 * |
4,6% | Vrij verhandelbaar | 99,12% |
Recentste transcriptie over Takeda Pharmaceutical Company Limited
1 dag | +3,47% | ||
1 week | +3,47% | ||
Lopende maand | +3,47% | ||
1 maand | +0,93% | ||
3 maanden | -5,74% | ||
6 maanden | -4,26% | ||
Lopend jaar | -6,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 01-04-14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-02-22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 01-01-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 71 | 01-06-16 | |
Ian Clark
BRD | Director/Board Member | 62 | 01-01-19 |
Steven Gillis
BRD | Director/Board Member | 71 | 01-01-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-06-24 | 26,86 | +3,47% | 9 483 |
uitgestelde koers OTC Markets, 03 juni 2024 om 21:37 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,69% | 750 mld. | |
+34,11% | 606 mld. | |
-6,87% | 356 mld. | |
+18,74% | 326 mld. | |
+6,76% | 286 mld. | |
+18,08% | 246 mld. | |
-3,44% | 213 mld. | |
+11,35% | 213 mld. | |
+2,64% | 167 mld. |
- Beurs
- Aandelen
- Koers 4502
- Koers TKPHF